Lowenstein PR - Search Results

1

Glioblastoma Utilizes Fatty Acids and Ketone Bodies for Growth Allowing Progression during Ketogenic Diet Therapy.

Sperry J, Condro MC, Guo L, Braas D, Vanderveer-Harris N, Kim KKO, Pope WB, Divakaruni AS, Lai A, Christofk H, Castro MG, Lowenstein PR, Le Belle JE, Kornblum HI. Sperry J, et al. Among authors: lowenstein pr. iScience. 2020 Aug 13;23(9):101453. doi: 10.1016/j.isci.2020.101453. eCollection 2020 Sep 25. iScience. 2020. PMID: 32861192 Free PMC article.

2

Antibodies to neuropeptide precursors expressed as fusion proteins in E. coli. Their use to examine neuropeptide biosynthetic pathways, intracellular trafficking and physiological activities.

Castro MG, Lowry PJ, Lowenstein PR. Castro MG, et al. Among authors: lowenstein pr. Int J Biochem. 1992 Jun;24(6):847-60. doi: 10.1016/0020-711x(92)90089-j. Int J Biochem. 1992. PMID: 1612176 Review. No abstract available.

3

Politically correct gene therapy? A "clean environment" improves gene delivery to the brain!

Lowenstein PR, Thomas CE, Castro MG. Lowenstein PR, et al. Gene Ther. 1999 Apr;6(4):463-4. doi: 10.1038/sj.gt.3300917. Gene Ther. 1999. PMID: 10476205 No abstract available.

4

Generation of a recombinant herpes simplex virus type 1 expressing the rat corticotropin- releasing hormone precursor: endoproteolytic processing, intracellular targeting and biological activity.

Tomasec P, Preston CM, Linton EA, Ahmed I, Lowenstein PR, Castro MG. Tomasec P, et al. Among authors: lowenstein pr. Neuroendocrinology. 1999 Dec;70(6):439-50. doi: 10.1159/000054506. Neuroendocrinology. 1999. PMID: 10657737

5

Cell-type specific expression in the pituitary: physiology and gene therapy.

Castro MG, Windeatt S, Smith-Arica J, Lowenstein PR. Castro MG, et al. Among authors: lowenstein pr. Biochem Soc Trans. 1999 Dec;27(6):858-63. doi: 10.1042/bst0270858. Biochem Soc Trans. 1999. PMID: 10830117 Review. No abstract available.

6

The basic science of brain-tumour gene therapy.

Lowenstein PR, Cowen R, Thomas C, Castro MG. Lowenstein PR, et al. Biochem Soc Trans. 1999 Dec;27(6):873-81. doi: 10.1042/bst0270873. Biochem Soc Trans. 1999. PMID: 10830120 Review. No abstract available.

7

Recent developments in gene therapy: applications for the treatment of pituitary tumours.

Castro MG, Davis JR, Xiong W, Lowenstein PR. Castro MG, et al. Among authors: lowenstein pr. Baillieres Best Pract Res Clin Endocrinol Metab. 1999 Oct;13(3):431-49. doi: 10.1053/beem.1999.0035. Baillieres Best Pract Res Clin Endocrinol Metab. 1999. PMID: 10909434 Review.

8

Molecular therapy in a model neuroendocrine disease: developing clinical gene therapy for pituitary tumours.

Castro MG, Southgate T, Lowenstein PR. Castro MG, et al. Among authors: lowenstein pr. Trends Endocrinol Metab. 2001 Mar;12(2):58-64. doi: 10.1016/s1043-2760(00)00358-1. Trends Endocrinol Metab. 2001. PMID: 11167123 Review.

9

Death receptor-independent cytochrome c release and caspase activation mediate thymidine kinase plus ganciclovir-mediated cytotoxicity in LN-18 and LN-229 human malignant glioma cells.

Glaser T, Castro MG, Löwenstein PR, Weller M. Glaser T, et al. Among authors: lowenstein pr. Gene Ther. 2001 Mar;8(6):469-76. doi: 10.1038/sj.gt.3301415. Gene Ther. 2001. PMID: 11313826

10

Genetic engineering within the adult brain: implications for molecular approaches to behavioral neuroscience.

Lowenstein PR, Castro MG. Lowenstein PR, et al. Physiol Behav. 2001 Aug;73(5):833-9. doi: 10.1016/s0031-9384(01)00520-0. Physiol Behav. 2001. PMID: 11566216 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

339 results

Search Page